Bipolar disease is a serious ailment that impacts the brain and distorts how people feel. Both disorders can be treated with medications, but their causes and manifestations are significantly distinct. In this case, bipolar I disease is the most serious type of ailment. It varies from other types of bipolar disorder in that it has a long duration of mania and anxiety. Meniere’s disease is distinguished by extreme chattiness, restlessness, and effort, as well as irritability and careless behavior. Mania is characterized by an increase in chattiness, anxiousness, and activity, as well as an increment in exasperation and careless behavior (McIntyre et al., 2020).
Bipolar II disorder is a milder form of bipolar disorder. It is distinguished by periods of regular emotion preceded by days or months of gentle depressive episodes. Individuals who are sorrowful throughout bipolar II disorder’s depressive durations may encounter feelings of unworthiness, sorrow, or a willingness to disengage from others. Individuals suffering from bipolar II disorder frequently experience periods of normal life, or “up” moods. Some of the symptoms include being more sociable and extroverted than usual, being more productive and energized, and having more ambition.
Bipolar II disorder, also referred to as hypomania, is a milder form of bipolar disorder than bipolar I. It has episodes of anxiety and is less intense in aspects of “down” signs than bipolar I ailment. Bipolar II differs from bipolar I in that it has distinguishable manic and depressive symptoms. Bipolar II has a less distinguishable interstitial process that comprises of weakened hypomania or depressive health conditions in between phases of depressive episodes (Lee et al., 2020). Bipolar II disorder signs are less intense and arise less frequently than bipolar I disorder manifestations. Both types of bipolar abnormality have manic and depressive incidents. Even though bipolar II ailment is less intense than bipolar I, it is still a dangerous disorder that requires medical attention.
References
Lee, S. Y., Lu, R. B., Wang, L. J., Chang, C. H., Lu, T., Wang, T. Y., & Tsai, K. W. (2020). Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder. Scientific reports, 10(1), 1-10.
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., … & Mansur, R. B. (2020). Bipolar disorders. The Lancet, 396(10265), 1841-1856.
Leave a Reply